Funding
Turn ideas into impact
Show Me
Due: September 7, 2026
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-040
Due: September 7, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
US $200,000
Type
Grant
Source
Federal
Opp Number
PAR-25-096
Due: September 7, 2026
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-064
Due: September 7, 2026
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-037
Due: September 7, 2026
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-347
Due: September 7, 2026
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-067
Due: September 7, 2026
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
Type
Grant
Source
Federal
Opp Number
PAR-23-235
Due: September 7, 2026
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-039
Due: September 7, 2026
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-153
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?